233 related articles for article (PubMed ID: 35211843)
1. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
[TBL] [Abstract][Full Text] [Related]
2. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
[TBL] [Abstract][Full Text] [Related]
3. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
Singh V; Yeoh BS; Abokor AA; Golonka RM; Tian Y; Patterson AD; Joe B; Heikenwalder M; Vijay-Kumar M
Gut Microbes; 2020 Jul; 11(4):1077-1091. PubMed ID: 32223398
[TBL] [Abstract][Full Text] [Related]
6. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
[TBL] [Abstract][Full Text] [Related]
7. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
8. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
Sitkin S; Pokrotnieks J
Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
[TBL] [Abstract][Full Text] [Related]
9. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.
Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y
Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
[TBL] [Abstract][Full Text] [Related]
11. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.
Yamada S; Takashina Y; Watanabe M; Nagamine R; Saito Y; Kamada N; Saito H
Oncotarget; 2018 Feb; 9(11):9925-9939. PubMed ID: 29515780
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
[TBL] [Abstract][Full Text] [Related]
13. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
[TBL] [Abstract][Full Text] [Related]
15. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial.
Wan Y; Yuan J; Li J; Li H; Zhang J; Tang J; Ni Y; Huang T; Wang F; Zhao F; Li D
Clin Nutr; 2020 Feb; 39(2):395-404. PubMed ID: 30876827
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease.
Shi Z; Chen G; Cao Z; Wu F; Lei H; Chen C; Song Y; Liu C; Li J; Zhou J; Lu Y; Zhang L
J Agric Food Chem; 2021 Apr; 69(13):3982-3991. PubMed ID: 33755449
[TBL] [Abstract][Full Text] [Related]
17. A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases.
Adhikari AA; Ramachandran D; Chaudhari SN; Powell CE; Li W; McCurry MD; Banks AS; Devlin AS
ACS Chem Biol; 2021 Aug; 16(8):1401-1412. PubMed ID: 34279901
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin alleviates cholestatic liver injury by decreasing gut microbiota-associated bile salt hydrolase activity in rats.
Ma Y; Wang H; Yang J; Xin M; Wu X
Eur J Pharmacol; 2023 Jul; 951():175790. PubMed ID: 37179041
[TBL] [Abstract][Full Text] [Related]
20. Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression.
Yang R; Qian L
Integr Cancer Ther; 2022; 21():15347354221114100. PubMed ID: 35880833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
